Hong Kong, China

Sze Tsai Alice Wong

This inventor holds 1 USPTO granted patent. Top assignee: Versitech, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sze Tsai Alice Wong. Retrieved from https://idiyas.com/inventor/sze-tsai-alice-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sze Tsai Alice Wong: Innovator in Metastatic Cell Detection

Introduction

Sze Tsai Alice Wong is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of medical technology, particularly in the detection and isolation of metastatic cells. Her innovative work has the potential to enhance cancer diagnostics and treatment.

Latest Patents

Wong holds a patent for a method titled "Method for peritoneal metastatic cell detection and isolation thereof." This patent describes a technique for detecting and isolating metastatic cells from samples obtained from subjects. The invention also includes a device featuring a microchip designed for use in this method. Additionally, it outlines a method for isolating metastatic cells for culture and characterization, along with a kit for implementing the method.

Career Highlights

Sze Tsai Alice Wong is associated with Versitech, Inc., where she continues to advance her research and development efforts. Her work is instrumental in bridging the gap between laboratory research and practical medical applications.

Collaborations

Wong collaborates with talented individuals such as Ho Cheung Anderson Shum and Shanshan Li, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sze Tsai Alice Wong's contributions to the field of metastatic cell detection exemplify the impact of innovative thinking in medical technology. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…